Department of Cardiology, Vestfold Hospital Trust, Toensberg, Norway.
Am J Cardiol. 2010 Jan 1;105(1):36-42. doi: 10.1016/j.amjcard.2009.08.641.
The aim of the present study was to investigate whether the implementation of an early invasive strategy for unselected patients with acute myocardial infarction (AMI) would be associated with reduced long-term mortality compared to a conservative approach. In this prospective observational cohort study of consecutive patients admitted for AMI in 2003 (conservative cohort, n = 311) and 2006 (invasive cohort [IC], n = 307), an 11% absolute and 41% relative reduction in 1-year mortality was found for patients with AMI in the IC compared to the conservative cohort (p = 0.001). These findings were consistent after adjustment for age, gender, previous AMI, previous stroke, diabetes, smoking status, previous left ventricular systolic dysfunction, and serum creatinine at admission (hazard ratio 0.54, 95% confidence interval 0.38 to 0.78) and Global Registry of Acute Coronary Events risk score (hazard ratio 0.67, 95% confidence interval 0.46 to 0.97). More patients with ST-segment elevation myocardial infarction received primary percutaneous coronary intervention in the IC (57% vs 3%, p <0.001), and a sixfold (25% vs 4%, p <0.001) increase in early percutaneous coronary intervention (<72 hours) for patients with non-ST-segment elevation myocardial infarction was observed. A greater proportion of patients in the IC received clopidogrel, aspirin, and statins during follow-up; otherwise, the secondary prevention measures were similar in the 2 cohorts. In conclusion, the introduction of a strategy for routine transfer to a high-volume percutaneous coronary intervention center for early invasive therapy was accompanied by a substantial reduction in mortality among unselected patients with AMI. Differences in unmeasured confounders might have accounted for a part of the difference in outcome.
本研究旨在探讨对于急性心肌梗死(AMI)患者,实施早期侵入性策略是否比保守策略能降低长期死亡率。在这项连续纳入的 2003 年(保守组,n = 311)和 2006 年(介入组[IC],n = 307)AMI 患者的前瞻性观察性队列研究中,与保守组相比,IC 组的 AMI 患者 1 年死亡率降低了 11%(绝对差异)和 41%(相对差异)(p = 0.001)。在校正年龄、性别、既往 AMI、既往卒中等混杂因素后,结果仍然一致(风险比 0.54,95%置信区间 0.38 至 0.78)和全球急性冠状动脉事件登记风险评分(风险比 0.67,95%置信区间 0.46 至 0.97)。更多 ST 段抬高型心肌梗死患者在 IC 接受了直接经皮冠状动脉介入治疗(57% vs 3%,p <0.001),而非 ST 段抬高型心肌梗死患者的早期经皮冠状动脉介入治疗(<72 小时)增加了 6 倍(25% vs 4%,p <0.001)。在随访期间,IC 组中有更大比例的患者接受了氯吡格雷、阿司匹林和他汀类药物;否则,两组的二级预防措施相似。总之,对于 AMI 患者,常规转至大容量经皮冠状动脉介入治疗中心进行早期侵入性治疗的策略的引入,伴随着死亡率的显著降低。未测量的混杂因素的差异可能导致了部分结果的差异。